case_images: PMC11197896_01
case_images: Optical coherence tomography (OCT) infrared images of the optic nerves at presentation: (a) right eye; (b) left eye, both showing papilloedema. OCT infra-red images at 2 months, following treatment: (c) right eye; (d) left eye, both without papilloedema.
case_images: IOPH_A_2301359_F0001_B.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0001_B.jpg
case_images: f0001
case_images: His optical coherence tomography (OCT) images quantitatively revealed the extent of the papilloedema, with global peripapillary retinal nerve fibre layer (RNFL) thicknesses of 466 microm in the right eye and 437 microm in the left (Figures 1 and 2). At 2 months, the papilloedema had resolved with global peripapillary RNFL thicknesses of 102 microm in the right eye and 81 microm in the left eye (Figures 1 and 5).
case_images: Optical coherence tomography retinal nerve fibre layer thickness (RNFL) at presentation showing increased thicknesses of the RNFL: (a) right eye and (b) left eye.
case_images: IOPH_A_2301359_F0002_PB.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0002_PB.jpg
case_images: f0002
case_images: His optical coherence tomography (OCT) images quantitatively revealed the extent of the papilloedema, with global peripapillary retinal nerve fibre layer (RNFL) thicknesses of 466 microm in the right eye and 437 microm in the left (Figures 1 and 2).
case_images: Computed tomography scans (upper row) and magnetic resonance imaging (lower row) showing a partially empty sella turcica and small ventricles, suggestive of intracranial hypertension.
case_images: IOPH_A_2301359_F0003_PB.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0003_PB.jpg
case_images: f0003
case_images: Computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the head showed a partially empty sella turcica, distortion of the optic nerves and narrowing of the transverse sinuses; features suggestive of intracranial hypertension (Figure 3).
case_images: Goldmann visual fields in the (a) Left eye and (b) Right eye at 2 months, following treatment.
case_images: IOPH_A_2301359_F0004_PB.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0004_PB.jpg
case_images: f0004
case_images: His relative afferent pupillary defect had resolved, and his visual field had subjectively improved (Figure 4).
case_images: Optical coherence tomography retinal nerve fibre layer thicknesses at 2 months, following treatment: (a) right eye and (b) left eye.
case_images: IOPH_A_2301359_F0005_PB.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0005_PB.jpg
case_images: f0005
case_images: At 2 months, the papilloedema had resolved with global peripapillary RNFL thicknesses of 102 microm in the right eye and 81 microm in the left eye (Figures 1 and 5).
case_images: Optical coherence tomography macular ganglion cell analysis: (a) right eye at presentation; (b) left eye at presentation; (c) right eye at 2 months, following treatment and; (d) left eye at 2 months, following treatment.
case_images: IOPH_A_2301359_F0006_PB.jpg
case_images: PMC11197896_01_IOPH_A_2301359_F0006_PB.jpg
case_images: f0006
case_images: His macular ganglion cell layer at 2 months was abnormal with specific loss in the temporal macular regions, worse in the left eye (Figure 6).